Published by Alexander Bueso on 7th September 2021
(Sharecast News) - Analysts at Liberum hiked their target price for shares of Dechra Pharmaceuticals but kept their recommendation at 'sell', telling clients that they struggled to justify such a lofty valuation.
URL: http://www.digitallook.com/dl/news/story/32105475/...